您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (7): 123-128.doi: 10.6040/j.issn.1671-7554.0.2021.1347

• 临床医学 • 上一篇    下一篇

儿童面部色素痣分期切除对比一期切除的成本-效果分析

李宏文1,周子芙1,王耸1,霍然1,2   

  1. 1.山东大学附属省立医院整形美容外科, 山东 济南 250021;2.山东第一医科大学附属省立医院整形美容外科, 山东 济南 250021
  • 发布日期:2022-07-27
  • 通讯作者: 霍然. E-mail:huoran@medmail.com.cn
  • 基金资助:
    国家自然科学基金(82172227)

Cost-effectiveness analysis of staged excision compared with one-stage excision of facial pigmented nevus in children

LI Hongwen1, ZHOU Zifu1, WANG Song1, HUO Ran1,2   

  1. 1. Department of Plastic and Cosmetic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China;
    2. Department of Plastic and Cosmetic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2022-07-27

摘要: 目的 从临床及卫生经济学的角度评价儿童面部先天性色素痣一期切除手术和分期切除手术的效果,并进行成本-效果分析。 方法 回顾性分析2018年6月至2019年6月就诊于山东省立医院整形美容外科的面部先天性色素痣患儿的临床资料58例,按照手术方式将患儿分成一期切除组(30例)和分期切除组(28例)。收集术后6个月刀口瘢痕的长度、宽度和面积以评估手术效果,收集两组的直接成本和间接成本。应用增量成本效果比值(ICER)进行成本-效果分析。 结果 两组患者均顺利完成手术,一期切除组和分期切除组所产生的总治疗成本分别为7 824.52(6 620.51,8 445.64)元和14 769.99(13 971.52,14 769.99)元,分期切除组明显高于一期切除组(P<0.001)。术后瘢痕面积与术前色素痣面积相比,一期切除组减少0.29(0.10,0.79)cm2,分期切除组减少0.95(0.29,2.59)cm2,分期切除组明显高于一期切除组(P=0.02)。增量成本效果分析显示,一期切除组患者病损面积每减少1 cm2需花费26 981.10元,分期切除组病损面积每减少1 cm2需花费15 547.36元。 结论 分期切除面部先天性色素痣相比于一期切除,术后不额外增加瘢痕长度,而且在处理较宽的病损时,也不增加瘢痕宽度。分期切除虽然会给患者增加额外的成本,但是分期切除仍是一种ICER更优的手术治疗色素痣的方案。

关键词: 先天性色素痣, 分期切除术, 一期切除术, 成本-效果分析

Abstract: Objective To compare the clinical effectiveness of one-stage excision and staged excision in children with congenital facial nevus by using clinical health economics evaluation method and to evaluate their cost-effectiveness. Methods A retrospective analysis was performed on the clinical data of 58 children with congenital facial nevus who visited Shandong Provincial Hospital from June 2018 to June 2019. The patients were divided into one-stage excision group(n=30)and staged excision group(n=28)according to the surgical operation. The length, width and area of the scar six months after the surgery were collected to evaluate the effectiveness of the surgery. The direct, indirect costs of two groups were also collected. Cost-effectiveness was analyzed using incremental cost-effectiveness ratio(ICER). Results All the patients completed the operation successfully. The total cost of the staged excision group was significantly higher than that of the one-stage excision group [14 769.99(13 971.52,14 769.99)yuan vs 7 824.52(6 620.51,8 445.64)yuan, P<0.001]. The postoperative area reduction of the scar in the staged excision group was 0.95(0.29,2.59)cm2, which was higher than that in the one-staged group [0.29(0.1,0.79)cm2; P=0.02]. The ICER analysis indicated that the patients in one-stage excision group spent 26 981.10 yuan for 1 cm2 area reduction and the patients in staged excision group spent 15 547.36 yuan for 1 cm2 area reduction. Conclusion Compared with the one-stage excision, the staged excision of congenital pigmented nevus on the face does not increase the length and width of the scar after the operation even for the wider lesions. Although staged excision increases extra costs for the patient, but it is still a better surgical treatment of pigmented nevi with a better ICER.

Key words: Congenital melanocytic nevi, Staged excision, One-stage excision, Cost-effectiveness analysis

中图分类号: 

  • R622+.9
[1] Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi[J]. J Am Acad Dermatol, 2013, 68(3): 441-451.
[2] Krengel S, Hauschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review[J]. Br J Dermatol, 2006, 155(1): 1-8.
[3] Masnari O, Schiestl C, Rössler J, et al. Stigmatization predicts psychological adjustment and quality of life in children and adolescents with a facial difference[J]. J Pediatr Psychol, 2013, 38(2): 162-172.
[4] Neuhaus K, Landolt M, Vojvodic M, et al. Surgical treatment of children and youth with congenital melanocytic nevi: self- and proxy-reported opinions[J]. Pediatr Surg Int, 2020, 36(4): 501-512.
[5] 周子芙,张瑾,王耸,等.78例儿童先天性面部色素痣分期切除结合外扩张的美容效果[J].山东大学学报(医学版), 2021, 59(2): 71-75. ZHOU Zifu, ZHANG Jin, WANG Song, et al. Cosmetic effects of staged resection of congenital facial nevus combined with external dilatation in 78 children [J]. Journal of Shandong University(Health Sciences), 2021, 59(2): 71-75.
[6] Ott H, Krengel S, Beck O, et al. Multidisciplinary long-term care and modern surgical treatment of congenital melanocytic nevi—recommendations by the CMN surgery network[J]. J Dtsch Dermatol Ges, 2019, 17(10): 1005-1016.
[7] Arad E, Zuker RM. The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications[J]. Plast Reconstr Surg, 2014, 133(2): 367-376.
[8] Liu H, Yu N, Shi J, et al. A new modified S-plasty for skin defect closure[J]. Aesthetic Plast Surg, 2015, 39(1): 100-105.
[9] Iida N, Watanabe A, Kusano T. Usefulness of S-shaped incision in large nevus sequential excision[J]. Plast Reconstr Surg Glob Open, 2014, 2(10): e224.
[10] Mutti LdA, Mascarenhas MRM, Paiva JMGd, et al. Giant congenital melanocytic nevi: 40 years of experience with the serial excision technique[J]. An Bras Dermatol, 2017, 92(2): 256-259.
[11] Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine[J]. JAMA, 2016, 316(10): 1093-1103.
[12] Sanders GD, Maciejewski ML, Basu A. Overview of cost-effectiveness analysis[J]. JAMA, 2019, 321(14): 1400-1401.
[13] OMahony JF. Does cost-effectiveness analysis really need to abandon the incremental cost-effectiveness ratio to embrace net benefit?[J]. Pharmacoeconomics, 2020, 38(8): 777-779.
[14] Leshem D, Gur E, Meilik B, et al. Treatment of congenital facial nevi[J]. J Craniofac Surg, 2005, 16(5): 897-903.
[15] 祁方家,卢建龙,冯莎,等.药物经济学评价中常见的成本及其测算方法[J].上海医药, 2015, 36(1): 7-9, 13. QI Fangjia, LU Jianlong, FENG Sha, et al. Common costs and their estimation methods in pharmacoeconomics [J]. Shanghai Medical & Pharmaceutical Journal, 2015, 36(1): 7-9, 13.
[16] Breuninger H, Häfner HM. Serial excision with power stretching for large and giant melanocytic nevi of the trunk[J]. J Dtsch Dermatol Ges, 2019, 17(8): 852-855.
[17] 顾子春,李华,叶学红,等.分次切除在皮肤病损治疗中的应用价值[J].全科医学临床与教育, 2007, 5(2): 119-121. GU Zichun, LI Hua, YE Xuehong, et al. The application value of fractional resection in treatment of skin lesion [J]. Clinical Education of General Practice, 2007, 5(2): 119-121.
[18] Lim JM, Oh Y, Lee SH, et al. Comparison of treatment options for small to medium congenital melanocytic nevi: a retrospective review of 119 cases[J]. Lasers Surg Med, 2019, 51(1): 62-67.
[19] Fahradyan A, Wolfswinkel EM, Tsuha M, et al. Cosmetically challenging congenital melanocytic nevi[J]. Ann Plast Surg, 2019, 82(5S Suppl 4): S306-S309.
[20] Hassanein AH, Rogers GF, Greene AK. Management of challenging congenital melanocytic nevi: outcomes study of serial excision[J]. J Pediatr Surg, 2015, 50(4): 613-616.
[21] 王振宇,逯艳,余睿芳,等.鱼嘴形切口在色素痣分次手术切除中的临床应用[J].中国美容医学, 2019, 28(4): 125-127. WANG Zhenyu, LU Yan, YU Ruifang, et al. The clinical application of fish-mouth shaped incision used in fractional surgical resection of pigmented nevus [J]. Chinese Journal of Aesthetic Medicine, 2019, 28(4): 125-127.
[22] Fife DJ, Alam M. Alternative techniques for reduction of scar length during staged excision[J]. J Am Acad Dermatol, 2011, 65(4): 811-818.
[23] Neumann PJ, Sanders GD. Cost-effectiveness analysis 2.0[J]. N Engl J Med, 2017, 376(3): 203-205.
[24] 张楠,石学峰,吴晶.增量成本效果比在卫生技术评估中的应用[J].中国卫生政策研究, 2012, 5(2): 64-68. ZHANG Nan, SHI Xuefeng, WU Jing. The application of incremental cost-effectiveness ratio to health technology assessment [J]. Chinese Journal of Health Policy, 2012, 5(2): 64-68.
[25] 陈英耀,董恒进,吕军,等.临床经济学概述[J].中华医院管理杂志, 2000, 16(6): 54-56.
[1] 董雪,赵霞,程子捷,韩毅. 左西孟旦和米力农治疗重症心力衰竭合并肾损伤患者711例的药物经济学评价[J]. 山东大学学报 (医学版), 2022, 60(4): 91-98.
[2] 周子芙,张瑾,王耸,李志宇,冶小云,毕见海,徐广琪,张健,吕仁荣,霍然. 78例儿童先天性面部色素痣分期切除结合外扩张的美容效果[J]. 山东大学学报 (医学版), 2021, 59(2): 71-75.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1 -6 .
[2] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7 -14 .
[3] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24 -31 .
[4] 徐玉香,刘煜东,张蓬,段瑞生. 101例脑小血管病患者脑微出血危险因素的回顾性分析[J]. 山东大学学报 (医学版), 2020, 1(7): 67 -71 .
[5] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32 -37 .
[6] 肖娟,肖强,丛伟,李婷,丁守銮,张媛,邵纯纯,吴梅,刘佳宁,贾红英. 两种甲状腺超声数据报告系统诊断效能的比较[J]. 山东大学学报 (医学版), 2020, 1(7): 53 -59 .
[7] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60 -66 .
[8] 吕龙飞,李林,李树海,亓磊,鲁铭,程传乐,田辉. 腔镜下细针导管空肠造瘘在微创McKeown食管癌切除术中的应用[J]. 山东大学学报 (医学版), 2020, 1(7): 77 -81 .
[9] 张娟,张璐嘉,肖伟,李顺平. 住院医师规范化培训学员压力知觉与留职意愿及影响因素[J]. 山东大学学报 (医学版), 2020, 1(7): 108 -114 .
[10] 徐继禧,陈伟健. 髓内弥漫性中线胶质瘤伴H3 K27M突变1例[J]. 山东大学学报 (医学版), 2020, 1(7): 96 -101 .